All Events
Canadian Science Policy Centre
1595 16th Avenue, Suite 301
Richmond Hill, ON
L4B 3N9
E-mail:
info@sciencepolicy.ca
Subscribe to the Canadian Science Policy Conference newsletter to keep up-to-date with the latest news, events and programs.
Innovation Policy refers to policies and public strategies, regulations, and initiatives aimed at promoting the development, diffusion, and application of new ideas, technologies, products, and services. It seeks to enhance capacity for innovation to drive economic growth, competitiveness, and social well-being. Innovation policy encompasses support for research and development (R&D), entrepreneurship and education, digital infrastructure, social innovation and collaboration between industry, academia, and government.
Science for Policy refers to the use of scientific knowledge, evidence, and expertise to inform and support decision-making in public policy. It involves translating complex scientific research into accessible insights that can guide the development, implementation, and evaluation of policies across various sectors, including (but not limited to) health, environment, technology, security, education, justice. Science for policy emphasizes evidence-based policymaking, where decisions are grounded in reliable data and research and knowledge rather than opinion or ideology.
Policy for Science refers to the set of governmental policies or institutional strategies, decisions, and frameworks that shape the funding, priorities, infrastructure, and governance of scientific research and development. It involves creating conditions that support scientific innovation, including investments in research institutions, training of scientists and development of science infrastructure, research integrity, EDIA, and international collaboration, ultimately aiming to strengthen the scientific enterprise to advance knowledge,economic development, and societal well-being.
Science for Policy refers to the use of scientific knowledge, evidence, and expertise to inform and support decision-making in public policy. It involves translating complex scientific research into accessible insights that can guide the development, implementation, and evaluation of policies across various sectors, including (but not limited to) health, environment, technology, security, education, justice. Science for policy emphasizes evidence-based policymaking, where decisions are grounded in reliable data and research and knowledge rather than opinion or ideology.
Science & Society refers to areas that strengthen public understanding and engagement with science, including the relationship between science and society. This includes but is not limited to science communication, education, journalism, public engagement, and citizen science and more.
Dr. Kelly Bannister is Co-Director of the POLIS Project on Ecological Governance and leads the POLIS Biocultural Ethics work. She is an ethnobiologist with post-doctoral training and over 20 years experience in applied ethics. Her work encompasses collaborative approaches to biocultural diversity research and education, biodiversity policy, and biocultural ethics as an emerging area of praxis. Kelly’s focus is on ethical and legal issues in research involving biodiversity and Indigenous cultural knowledge. She works in collaboration with a number of non-profit, Indigenous, and community organizations, as well as federal and provincial governments. She has extensive experience in ethics policy analysis and development within Canada and internationally.
Kelly holds B.Sc., Biochemistry/Microbiology and M.Sc., Microbial genetics degrees from the University of Victoria Department of Biochemistry and Microbiology and a Ph.D., Ethnobotany/Phytochemistry from the University of British Columbia Department of Botany. After completing her Ph.D., she undertook post-doctoral research positions in Ecological Governance related to community-based research and the protection of Indigenous knowledge.
Dr. Raymond Andersen is an international expert in the discovery of novel marine natural products with biological activities that make them useful as tools for chemical biology and new drug targets. Specifically, his lab continually collects marine invertebrates and bacteria from tropical and cold temperate ocean habitats and their extracts are screened for novel metabolites that are potential leads for the development of new anticancer drugs. In addition, marine bacteria are being examined as a source of novel antibiotics that are active against ‘antibiotic resistant’ human pathogens. He has been recognized at the highest level including being awarded the Chemical Institute of Canada Medal and Fellow at Royal Society of Canada.
Raymond holds a B.Sc., University of Alberta, M.Sc., University of California, Berkeley, and a Ph.D., University of California, San Diego.
Dr. Federica Di Palma is passionate about exploring and preserving biodiversity around the world. In addition to leading Genome BC’s research and innovation efforts across multiple sectors, she serves at the leadership team of the Earth Biogenome Project and as a Chair of the Project’s international scientific committee. She also leads numerous multidisciplinary international research programs for Development Assistance Committee countries aimed at generating strategic partnerships, building human and infrastructure capacity, and translating scientific knowledge into policy and private sector engagement to deliver long-term impact. Federica remains Professorial Fellow in Biodiversity in the School of Biological Sciences at the University of East Anglia.
Federica holds a BSc, Cell and Molecular Biology from the University of Essex and a PhD, Immunogenetics, from the University of Reading.
Greg is the Senior Director of Breeding and Genetics at Aurora Cannabis, where he leads the development of new Cannabis cultivars and the discovery of the genetic basis of key traits. Previously he worked as a trait geneticist in Monsanto’s vegetable seed division, enabling marker-assisted selection in tomatoes for important disease and quality traits as well as building new hybrids with multiple disease tolerance traits. Baute earned his PhD at UBC in the Rieseberg lab working on sunflower genomics and breeding, with a focus on the use of wild relatives.
As a Genomics and Society Advisor at Genome BC, George’s work focuses on the ethical, environmental, economic, legal and social implications of genomics. Having worked in various roles in the intersection of innovation, social impact and public policy, George brings multiple perspectives. His previous roles include Senior Advisor at the Advanced Technologies Unit at the Ontario Ministry of Economic Development, Job Creation and Trade, researcher at the Innovation Policy Lab at the Munk School of Global Affairs and Public Policy at the University of Toronto, and intern at the United Nations in New York.
George is a Ph.D. Candidate in Political Science at the University of Toronto, focusing on collaborative strategies in innovation policies. He is a recipient of the SSHRC Canada Graduate Scholarships Doctoral Program. He holds an Associate of Arts, Anthropology, from Douglas College, a BA, International Studies, from Simon Fraser University, and a MA, Political Science, from the University of Toronto.